The University of Chicago Header Logo

Connection

Philip P. Connell to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Philip P. Connell has written about Biomarkers, Tumor.
Philip P. Connell
Connection Strength
0.199
Biomarkers, Tumor
  1. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.109
  2. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Mol Cancer Ther. 2019 03; 18(3):507-516.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.